L. Hillman et al., DECREASED BONE MINERALIZATION IN CHILDREN WITH PHENYLKETONURIA UNDER TREATMENT, European journal of pediatrics, 155, 1996, pp. 148-152
Children with phenylketonuria (PKU) obtain a great deal of their prote
in and mineral intakes from synthetic elemental formulae devoid of phe
nylalanine. To assess the effect of such diets and/or the disease on b
one mineralization, children with PKU were compared to normal children
for many parameters of mineral homeostasis and bone mineralization. A
total of 11 children with PKU of mean age 10.9 +/- 4.2 years were com
pared to a large group of normal control children mean age 11.4 +/- 4.
2, and an age and sex matched subset (n = 11). Children with PKU had l
ower serum calcium (9.1 +/- 0.9 vs 10.4 +/- 1.9 mg/dl P < 0.01) and ma
gnesium (1.67 +/- 1.4 vs 2.07 +/- 0.16 mg/dl, P < 0.001) but normal va
lues for phosphorus, zinc, and copper. The percentage tubular reabsorp
tion of phosphorus was increased in PKU (93 +/- 3% vs 88 +/- 6%, P < 0
.05) suggesting a lower phosphorus intake and/or absorption. Serum 25-
hydroxyvitamin D, parathyroid hormone and 1,25 dihydroxyvitamin D were
similar in PKU and control children. Serum albumin and lean body mass
by dual energy X-ray absorption were not different suggesting that pr
otein intake was adequate. In the 11 pairs, a decreased bone mineral d
ensity was seen for the lumbar spine (0.61 +/- 0.15 vs 0.72 +/- 0.24 P
< 0.05), and lower extremities (1.56 +/- 0.30 vs 1.87 +/- 0.56 P < 0.
05) by paired t-test. Compared to the total controls and the paired co
ntrols, decreases were seen in markers of bone formation; bone alkalin
e phosphatase, (72 +/- 30 vs 126 +/- 43 P < 0.001), osteocalcin (10.7
+/- 3.4 vs 13.1 +/- 2.0 P < 0.05) and procollagen type I carboxytermin
al propeptide. No differences were seen in the bone resorption markers
tartrate resistant acid phosphatase and urine Ca/Cr. The changes note
d could not be related after age correction to serum phenylalanine lev
els, protein intake, or mineral intakes. It is unclear whether deficit
s in bone mineralization relate to the disease process itself or its t
reatment.